Oragenics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,140 | $0 |
Gross Profit | -341 | 1,570 | -879 | |
EBITDA | -1,714 | -2,018 | -3,338 | -2,453 |
EBIT | -4,044 | -3,339 | -2,459 | |
Net Income | -2,272 | -2,217 | -3,349 | -2,463 |
Net Change In Cash | 0 | 0 | 3,140 | 0 |
Free Cash Flow | -1,314 | -2,112 | -2,018 | -1,970 |
Cash | 1,973 | 3,421 | 864 | 3,144 |
Basic Shares | 7 | 1 | 6,622 | 6,528 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $37 | $131 | $86 |
Gross Profit | -4,114 | -27 | 86 | 45 |
EBITDA | -10,559 | -20,878 | -14,229 | -15,654 |
EBIT | -10,597 | -20,905 | -14,273 | -15,695 |
Net Income | -10,568 | -20,656 | -14,288 | -15,711 |
Net Change In Cash | 0 | 37 | 131 | 86 |
Free Cash Flow | -8,597 | -7,290 | -15,356 | -13,514 |
Cash | 864 | 3,483 | 11,426 | 27,265 |
Basic Shares | 6,622 | 2,250 | 2,009 | 1,881 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$3.10 |
2025-03-31 | -$3.65 |
2024-12-31 | -$0.26 |
2024-09-30 | -$0.37 |
